Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitex Agnus-castus BNO 1095 in Primary Dysmenorrhea
NCT06211049Phase 3Completed
- Sponsor
- Bionorica
- Start
- Dec 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of cyclodynon in primary dysmenorrhea (PD), sponsored by Bionorica. Started Dec 2023; status: completed.
02
Drugs
cyclodynon
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT06211049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06211049.